Company

Amyl Therapeutics

Biotechnology Research Be 12 employees

Employees: 12
Contacts: 1
Emails: 1

www.amyltx.com LinkedIn Crunchbase

Amyl Therapeutics Overview

Headquarters: Be
Website: www.amyltx.com
Industry: Biotechnology Research
Employees: 12
Founded: 2020
Funding: 5.7M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

amyloidosis Alzheimer Parkinson Biopharmaceutical research

About Amyl Therapeutics

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

Amyl Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Amyl Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Damien Toulorge, Phd	Cso	Liège, Walloon Region, Belgium	Email
Aditya Iyer, Phd	Senior Pm @ Amyl Therapeutics - Driving		View
Karine Goraj	Strategic Advisor / Amyl Therapeutics	Liège, Walloon Region, Belgium	View